Michael S. Roberts

Royal Brisbane and Women's Hospital

Papers

1

Total Citations

33

H-Index

1

About

Michael S. Roberts is a leading urological oncologist whose research focuses on improving the diagnosis and staging of prostate cancer through advanced imaging. His major contributions center on comparing the efficacy of multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen positron emission tomography/computerized tomography (PSMA PET/CT) in detecting clinically significant disease. In his highly cited 2021 study (33 citations), Roberts demonstrated that mpMRI alone fails to identify some men with significant prostate cancer, while PSMA PET/CT offers additional diagnostic value for staging. By correlating preoperative imaging findings with totally embedded radical prostatectomy histopathology in over 1,100 men, his work provides crucial evidence for integrating PSMA PET/CT into clinical decision-making. This research has direct implications for reducing underdiagnosis and guiding more precise treatment strategies. Roberts’ findings are widely referenced in guidelines and practice, establishing him as a key voice in the evolution of prostate cancer management. His work continues to shape how clinicians balance imaging modalities to optimize patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
33
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Findings in 1,123 Men with Preoperative <sup>68</sup> Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer
33 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Royal Brisbane and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago